SEC Form 4/A · accession 0000903423-17-000244
HTG MOLECULAR DIAGNOSTICS, INC · HTGM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
GLAXOSMITHKLINE PLC
Other
Period of report
Mar 27, 2017
Accepted (ET)
Mar 30, 2017 · 4:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001169987
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Mar 27, 2017 | S | 300,000 | $10.1506 | D | 792,781 | I | By S.R. One, Limited |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Including 43,538 shares of the Issuer's Common Stock deliverable upon the exercise of a warrant that is exercisable at any time at an exercise price of $14.00.
- F2Shares are held of record by S.R. One, Limited, an indirect, wholly-owned subsidiary of GlaxoSmithKline plc (Reporting Person).
Remarks
This Form 4/A is being filed solely to correct the date in the signature block due to a typographical error made in the original Form 4 filed on March 29, 2017. No other changes have been made hereto.